IL234680A0 - Methods for distributing complement inhibitor drugs to patients receiving a complement inhibitor - Google Patents

Methods for distributing complement inhibitor drugs to patients receiving a complement inhibitor

Info

Publication number
IL234680A0
IL234680A0 IL234680A IL23468014A IL234680A0 IL 234680 A0 IL234680 A0 IL 234680A0 IL 234680 A IL234680 A IL 234680A IL 23468014 A IL23468014 A IL 23468014A IL 234680 A0 IL234680 A0 IL 234680A0
Authority
IL
Israel
Prior art keywords
complement
methods
distributing
patients receiving
inhibiting drugs
Prior art date
Application number
IL234680A
Other languages
English (en)
Hebrew (he)
Original Assignee
Alexion Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharma Inc filed Critical Alexion Pharma Inc
Publication of IL234680A0 publication Critical patent/IL234680A0/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
    • F04C2270/00—Control; Monitoring or safety arrangements
    • F04C2270/04—Force
    • F04C2270/041—Controlled or regulated

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL234680A 2012-03-16 2014-09-16 Methods for distributing complement inhibitor drugs to patients receiving a complement inhibitor IL234680A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2012/029499 WO2013137912A2 (en) 2012-03-16 2012-03-16 Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor

Publications (1)

Publication Number Publication Date
IL234680A0 true IL234680A0 (en) 2014-11-30

Family

ID=49161929

Family Applications (1)

Application Number Title Priority Date Filing Date
IL234680A IL234680A0 (en) 2012-03-16 2014-09-16 Methods for distributing complement inhibitor drugs to patients receiving a complement inhibitor

Country Status (6)

Country Link
EP (1) EP2825989A4 (de)
CN (1) CN104205155A (de)
EA (1) EA201400950A1 (de)
HK (1) HK1204693A1 (de)
IL (1) IL234680A0 (de)
WO (1) WO2013137912A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272142B2 (en) 2013-11-13 2019-04-30 Shire Viropharma Incorporated Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders
CN105260974A (zh) * 2015-09-10 2016-01-20 济南市儿童医院 一种生成具有告签功能的电子病历方法及系统
CN115177291B (zh) * 2022-08-01 2023-11-10 首都医科大学附属北京朝阳医院 用于识别重症监护病房获得性肌无力的方法和装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6315720B1 (en) * 2000-10-23 2001-11-13 Celgene Corporation Methods for delivering a drug to a patient while avoiding the occurrence of an adverse side effect known or suspected of being caused by the drug
US20040117126A1 (en) * 2002-11-25 2004-06-17 Fetterman Jeffrey E. Method of assessing and managing risks associated with a pharmaceutical product
US20050169921A1 (en) * 2004-02-03 2005-08-04 Leonard Bell Method of treating hemolytic disease
US20060062734A1 (en) * 2004-09-20 2006-03-23 Melker Richard J Methods and systems for preventing diversion of prescription drugs
US20090220508A1 (en) * 2006-03-15 2009-09-03 Alexion Pharmaceuticals, Inc. Treatment Of Paroxysmal Nocturnal Hemoglobinuria Patients By An Inhibitor Of Complement
US8478605B2 (en) * 2006-07-17 2013-07-02 Walgreen Co. Appropriateness of a medication therapy regimen
WO2008021954A2 (en) * 2006-08-09 2008-02-21 Biogen Idec Ma Inc. Method for distribution of a drug
CA2742802C (en) * 2008-11-10 2019-11-26 Alexion Pharmaceuticals, Inc. Methods and compositions for treating complement-associated disorders
WO2011091078A2 (en) * 2010-01-19 2011-07-28 Xencor, Inc. Antibody fc variants with enhanced complement activity

Also Published As

Publication number Publication date
WO2013137912A2 (en) 2013-09-19
EP2825989A2 (de) 2015-01-21
WO2013137912A3 (en) 2014-05-01
HK1204693A1 (en) 2015-11-27
EA201400950A1 (ru) 2014-12-30
EP2825989A4 (de) 2016-01-06
CN104205155A (zh) 2014-12-10

Similar Documents

Publication Publication Date Title
ZA201307862B (en) Controlled release pharmaceutical dosage forms
ZA201309297B (en) Tamper-resistant tablet providing immediate drug release
ZA201309299B (en) Tamper-resistant tablet providing immediate drug release
IL238713A0 (en) Self-regulating active pharmaceutical ingredient release
AU343318S (en) Medicine injector
PL3415139T3 (pl) Podawanie benzodiazepiny
IL237138A0 (en) Methods of administration of pirfenidone therapy
PL2870072T3 (pl) Dozownik leków
EP2688559A4 (de) Schluckbare medikamentenkapsel
EP2864361A4 (de) Dosierungsschema für fusionsverbindungen
IL229591A0 (en) Addition of medicine
GB201210628D0 (en) Oral medicine dispensing system
EP2836206A4 (de) Pharmazeutische formulierungen mit kontrollierter freisetzung von direkten thrombinhemmern
ZA201405797B (en) Pharmaceutical dosage form
AP2015008208A0 (en) Pharmaceutical administration forms comprising
SG11201404454VA (en) Improvements relating to medicament delivery devices
ZA201500909B (en) A pharmaceutical composition for stimulation of angiogenesis
IL234680A0 (en) Methods for distributing complement inhibitor drugs to patients receiving a complement inhibitor
EP2851074A4 (de) Analgetische pharmazeutische zusammensetzung
AP2014007760A0 (en) Stabilized pharmaceutical formulations of a potentHCV inhibitor
IL220794A (en) Medication dispenser
GB201104632D0 (en) Use of medicament
ZA201502354B (en) Pharmaceutical dosage form
IL237221A0 (en) Analogues of phospholipid drugs
GB201213729D0 (en) Manufacture of insoluble drugs